Specjalizacja w medycynie, partnerstwo w inwestycjach

Specialised in healthcare, focused on investment partnerships

EndoFund is a company with years of experience in medical contracts, specialising exclusively in factoring within the healthcare sector. We understand the market, its processes, and requirements, and we place strong emphasis on thorough verification of the counterparties we work with.

This allows us to offer both individual and corporate investors access to short-term investment opportunities.

Many of our investors choose to work with us on an ongoing basis, renewing their agreements and building a consistent, income-focused investment approach over time.


Consistent capital growth over time

Investors choose EndoFund for its reliability and often continue working with us over the long term. Many of them gradually increase both the number of agreements they enter into and the amount of capital they allocate.

EndoFund circulating capital

Why invest with us?

We combine experience, transparency, and strong investment returns:

Specjalizacja w faktoringu medycznym
Specialists in medical factoring

For years, we have operated exclusively in this sector, gaining deep insight into its processes and specifics. Our team is highly experienced in working with hospital contracts and the Polish public healthcare system (NFZ).

Rzetelna weryfikacja
Thorough partner verification

Each counterparty and agreement undergoes careful due diligence. We work exclusively with trusted factoring partners, which helps manage counterparty risk and supports a more predictable investment process.

Przejrzyste zasady wpółpracy
Transparent investment terms

Each investment is based on a clear agreement and a promissory note. The investor is informed in advance of the payment schedule, including interest payments and the repayment of the principal.

Atrakcyjny regularny zwrot
Regular and competitive returns

Interest is paid monthly, and the principal is repaid at the end of the agreement. Many investors choose to renew their investment, gradually increasing the amount of capital they allocate

EndoFund holds 100% of the shares in Phoenix Global Innovations S.A., a company operating under the supervision of the Polish Financial Supervision Authority (KNF).

In July 2025, the company underwent a positive review during an audit conducted by the KNF, which resulted in the establishment of Phoenix Global Innovations as an alternative investment company.

EndoFund has also received positive assessments from Bilecta Finanse and Saveland Fund, as well as a Business Credibility Certificate from Kaczmarski Group, confirming its financial stability and reliability as a business partner.

How does EndoFund work?

Our investment model is based on a transparent and structured process, with each stage designed to support capital preservation and provide a consistent, income-focused investment experience.

Rzetelna weryfikacja
Counterparty verification

Each medical company and hospital contract undergoes thorough due diligence. We work exclusively with entities that meet strict standards of reliability and financial stability.

Zawarcie umowy z inwestorem 2
Investment agreement with the investor

The investor selects the investment amount and then signs a clear and transparent agreement together with a promissory note, which specifies the exact maturity date and redemption value.

Finansowanie sprawdzonych kontraktów
Financing verified contracts

Capital entrusted to EndoFund is allocated to financing contracts between medical companies and hospitals. These contracts are based on funding from the Polish public healthcare system (NFZ), which contributes to a high level of predictability in cash flows.

Atrakcyjny regularny zwrot
Regular returns and income-focused investing

Interest is paid on a monthly basis, and at the end of the investment term, the investor receives the full principal. The process does not require active involvement, and many investors choose to renew their agreements, gradually increasing the amount of capital they allocate.

The people behind EndoFund

EndoFund is driven by an experienced team combining expertise in healthcare, finance, and business. We are professionals whose knowledge and commitment help build trust among investors and partners, ensuring a high standard of cooperation

Piotr Cioch
CEO, EndoFund S.A.
Founder, EndoLink
Finance and healthcare sector expert
Piotr Cioch - Endofund

Founder and CEO of EndoFund S.A. and Founder of EndoLink, with over 15 years of experience in finance, accounting, and the medical sector. He graduated in Finance and Accounting from the Faculty of Management at the University of Łódź.

From the beginning of his career, he has worked at the intersection of finance and healthcare, recognising the need for dedicated and flexible financing solutions within the healthcare sector.

As CEO of EndoLink Sp. z o.o., he introduced specialised medical technologies in Poland, focusing on vascular surgery, cardiac surgery, and interventional radiology. He is also a clinical specialist in the implantation of stent grafts for the treatment of thoracic and abdominal aortic aneurysms.

His practical understanding of hospital operations and the medical industry enabled him to establish EndoFund S.A. in 2018, addressing the key challenge of liquidity shortages among small and medium-sized medical suppliers and service providers.

His combined experience in banking and financial services, together with his knowledge of the healthcare system, forms the foundation of EndoFund’s operations.

Under his leadership, the company has grown steadily, expanding its investment portfolio and building long-term relationships with investors and partners. He is focused on the long-term development of EndoFund as a specialised healthcare financing company, with plans for international expansion and a potential listing on the NewConnect market.

Michał Gajewski
Chief Operating Officer – Authorized Signatory
Michał Gajewski - Endofund

With over 25 years of experience in the healthcare sector, specialising in investment management, sales, and development projects for healthcare providers. He combines managerial expertise with in-depth market knowledge, making him a trusted business partner and strategic advisor to healthcare institutions.

He serves on the boards of companies in the medical, financial, and technology sectors, overseeing product development and the optimisation of business models. At EndoFund, he is responsible for cooperation with medical companies, ensuring a careful selection of counterparties and maintaining high standards of partnership quality.

Ewa Szczegielniak
Director of Investor Relations
Ewa Szczegielniak - Endofund

With over 20 years of business experience, spanning both corporate leadership roles and the development of her own ventures. As Chief Sales Director, she led a 300-person team, and for over a decade she has run a consulting and digital agency, supporting companies in scaling their operations and leveraging market opportunities.

She is a business strategist and mentor, focused on building long-term, partnership-based relationships that create value for all parties involved. Her expertise in management, negotiation, and business development makes her a trusted professional in working with investors and business partners.

Build a consistent income stream with EndoFund

For years, we have been helping medical companies and investors align their goals within a structured investment model. If you are looking for an efficient way to allocate your capital, learn more about cooperation with EndoFund